These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10049191)

  • 21. [Anti-arrhythmic therapy of ventricular arrhythmias. Assessing benefit and risk].
    Haberl R; Steinbeck G
    Internist (Berl); 1993 May; 34(5):436-43. PubMed ID: 8509254
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of sotalol on RR interval variability during induced ventricular tachycardia.
    Yli-Mäyry S; García-Alberola A; Haverkamp W; Hindricks G; Martínez-Rubio A; Borggrefe M; Breithardt G
    Am J Cardiol; 1996 Aug; 78(3):372-6. PubMed ID: 8759826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sotalol in Life-Threatening Ventricular Arrhythmias: A Unique Class III Antiarrhythmic. Symposium proceedings. Phoenix, Arizona, September 19-22, 1991.
    Am J Cardiol; 1993 Aug; 72(4):1A-85A. PubMed ID: 8102220
    [No Abstract]   [Full Text] [Related]  

  • 24. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
    ; ; Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C; Smith SC; Jacobs AK; Adams CD; Antman EM; Anderson JL; Hunt SA; Halperin JL; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ;
    J Am Coll Cardiol; 2006 Sep; 48(5):e247-346. PubMed ID: 16949478
    [No Abstract]   [Full Text] [Related]  

  • 25. Suppression of ventricular tachycardia by sotalol in myotonic dystrophy.
    Cohen MB; Snow JS; Merkatz KA; Kholwadwala D; Jadonath RL; Goldner BG; Cohen TJ
    Am Heart J; 1996 Aug; 132(2 Pt 1):446-9. PubMed ID: 8701909
    [No Abstract]   [Full Text] [Related]  

  • 26. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
    Mitchell LB
    J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
    [No Abstract]   [Full Text] [Related]  

  • 27. Parenteral antiarrhythmic drug therapy in ventricular tachycardia/ventricular fibrillation: evolving role of class III agents--focus on amiodarone.
    Scheinman MM
    J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):914-9. PubMed ID: 8548112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias.
    Lee RJ; Wong M; Siu A; Namekawa-Wong M; Epstein LM; Fitzpatrick AP; Grogin HR; Scheinman MM; Lesh MD
    Am Heart J; 1996 Nov; 132(5):973-8. PubMed ID: 8892770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia.
    Kovoor P; Love A; Hall J; Kruit R; Sadick N; Ho D; Adelstein BA; Ross DL
    Intern Med J; 2005 Sep; 35(9):518-25. PubMed ID: 16105152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced cardiovascular life support Guidelines 2000: pharmacological changes to the treatment of ventricular fibrillation/pulseless ventricular tachycardia.
    Shuster M; Tang A
    Can J Cardiol; 2001 Oct; 17(10):1022-5. PubMed ID: 11694892
    [No Abstract]   [Full Text] [Related]  

  • 32. Does β-Blockade for Treatment of Refractory Ventricular Fibrillation or Pulseless Ventricular Tachycardia Improve Outcomes?
    Long DA; Long B; April MD
    Ann Emerg Med; 2020 Jul; 76(1):42-45. PubMed ID: 32192760
    [No Abstract]   [Full Text] [Related]  

  • 33. Implantable cardiac defibrillators.
    Spivack C
    N Engl J Med; 2002 Aug; 347(5):365-7; author reply 365-7. PubMed ID: 12154817
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute treatment of stable hemodynamically tolerable ventricular tachycardia].
    Haverkamp W; Rolf S; Stockburger M; Dietz R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):207-12. PubMed ID: 15832239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blockers for ventricular arrhythmias: have we underestimated their value?
    Campbell TJ
    Aust N Z J Med; 1996 Oct; 26(5):689-96. PubMed ID: 8958366
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome].
    Orczykowski M; Szumowski L; Szufladowicz E; Bodalski R; Zakrzewska-Koperska J; Walczak F
    Kardiol Pol; 2008 Jul; 66(7):800-4. PubMed ID: 18690576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent insights in programmed electrical stimulation for the management of sustained ventricular arrhythmias.
    Wood M; Stambler B; Ellenbogen K
    Curr Opin Cardiol; 1994 Jan; 9(1):3-11. PubMed ID: 8199368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and efficacy testing of sotalol.
    Mason JW
    J Am Coll Cardiol; 1999 Jan; 33(1):53-4. PubMed ID: 9935008
    [No Abstract]   [Full Text] [Related]  

  • 39. Amiodarone: the AHA's new drug of choice for victims of ventricular arrhythmias.
    Erich J
    Emerg Med Serv; 2000 Oct; 29(10):22. PubMed ID: 11140049
    [No Abstract]   [Full Text] [Related]  

  • 40. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).
    Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Le Heuzey JY; Kay GN; Lowe JE; Olsson SB; Prystowsky EN; Tamargo JL; Wann S; ; ; ;
    Eur Heart J; 2006 Aug; 27(16):1979-2030. PubMed ID: 16885201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.